XML 93 R59.htm IDEA: XBRL DOCUMENT v3.25.1
Equity Method Investments (Details) - USD ($)
11 Months Ended 12 Months Ended
Dec. 31, 2023
Dec. 31, 2024
Dec. 31, 2023
Feb. 09, 2024
Feb. 09, 2023
Equity Method Investments [Line Items]          
Equity Method Investment, Amount $ 12,095,020 $ 10,636,544 $ 12,095,020    
Impairment loss   454,679    
Purchased interests   20,666,667      
Preferred stock, value    
Equity method investment payable 666,667 666,667    
Cost of investment         $ 19,460,000
Estimated useful life   15 years      
Intangible assets 611,356 $ 666,932      
Recognized impairment loss 9,196,682 259,579      
Identified intangible assets 9,392,644 8,725,712 9,392,644    
Goodwill $ 259,579 0 $ 259,579    
Avalon Shangai [Member]          
Equity Method Investments [Line Items]          
Total ownership percentage 40.00%   40.00%    
Jiangsu Unicorn Biological Technology Co., Ltd.[Member]          
Equity Method Investments [Line Items]          
Total ownership percentage 60.00%   60.00%    
Series A Convertible Preferred Stock [Member]          
Equity Method Investments [Line Items]          
Preferred stock, value   9,000,000      
Series B Convertible Preferred Stock [Member]          
Equity Method Investments [Line Items]          
Preferred stock, value   $ 11,000,000      
Issuance shares (in Shares)   11,000      
Conversion price per share (in Dollars per share)   $ 56.7      
Aggregate of common stock (in Shares)   194,004      
Series B Stated Value [Member]          
Equity Method Investments [Line Items]          
Equity method investment payable       $ 666,667  
Lab Services MSO [Member]          
Equity Method Investments [Line Items]          
Lab services MSO’s net income $ 1,236,391 $ 79,923      
Epicon Biotech Co. Ltd [Member]          
Equity Method Investments [Line Items]          
Equity Method Investment, Amount 0   $ 0    
Impairment loss     454,679    
Investment in Epicon Biotech Co., Ltd. [Member]          
Equity Method Investments [Line Items]          
Impairment loss     $ (454,679)    
Lab Services MSO [Member]          
Equity Method Investments [Line Items]          
Ownership percentage   40.00%      
Distribution of earnings from investment $ 0 $ 611,888      
Lab Services [Member] | Minimum [Member]          
Equity Method Investments [Line Items]          
Ownership percentage   40.00%      
Lab Services [Member] | Maximum [Member]          
Equity Method Investments [Line Items]          
Ownership percentage   60.00%      
Series B Stated Value [Member]          
Equity Method Investments [Line Items]          
Preferred stock, value   $ 1,000